NFCR-funded translational cancer research project receives Virginia Catalyst grant
ROCKVILLE, MD – A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate. The funding will be used for collaboration among the laboratory of Virginia Commonwealth University’s (VCU) Paul Fisher, M.Ph., Ph.D., an NFCR fellow, a team at…